Embie Clinic
Enabling a 10X growth in Fertility Treatments in the US via Remote Fertility Treatment
Company Overview
Snapshot
Founded in May 2020 by Josh Gottesman, Ravid Israel, and Dana Averbuch, Embie Clinic operates with 1–10 employees. The company has raised $1.5M across two funding rounds. In October 2023, Embie Clinic went live with its initial paying fertility clinic customers.
Business overview
Embie Clinic specializes in remote fertility management within the Health Tech & Life Sciences sector. The company develops a suite of products designed to expand the geographic reach and enhance the operational efficiency of fertility clinics. Its core technology includes a mobile app that has demonstrated improved pregnancy success rates in peer-reviewed research. Embie Clinic serves the healthcare industry, specifically targeting fertility clinics and providers in global markets, with a focus on the United States.
Strategic signal
In October 2023, Embie Clinic announced it had gone live with its first paying fertility clinic customers. This milestone signals a transition from product development to commercialization, indicating market validation and the potential for revenue growth as the company expands its customer base in the US.
Company Intelligence Q&A
- What is Embie Clinic's primary focus?
- Embie Clinic focuses on enabling a 10X growth in fertility treatments in the US through remote fertility treatment solutions.
- When was Embie Clinic founded and by whom?
- Embie Clinic was founded in May 2020 by Josh Gottesman, Ravid Israel, and Dana Averbuch.
- What significant commercial milestone did Embie Clinic achieve in late 2023?
- In October 2023, Embie Clinic went live with its first paying fertility clinic customers, marking a key step in its commercialization strategy.
- How much capital has Embie Clinic raised to date?
- Embie Clinic has raised a total of $1.5M across two funding rounds.
- What is the primary function of Embie Clinic's mobile app?
- Embie Clinic's mobile app is designed to improve IVF outcomes, with peer-reviewed research supporting its effectiveness in boosting pregnancy success rates.